Shanghai Universal Biotech Co

Shanghai Universal Biotech Co R&D per Employee

The R&D Spending per Employee of Shanghai Universal Biotech Co (301166.SZ) as of Nov 1, 2026 is 97,398.05 CNY. In the previous year, R&D Spending per Employee was 91,234.88 CNY — a change of 6.76% (higher).

R&D per Employee

97,398.05CNY

YoY

6.76%

Last updated:

R&D Spending per Employee of Shanghai Universal Biotech Co is 2025 97,398.05 CNY. R&D Spending per Employee of Shanghai Universal Biotech Co was 2024 91,234.88 CNY. It decreases by 6.76% higher compared to the previous year.

The Shanghai Universal Biotech Co R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
8,085.03 CNY
Jan 1, 2019
12,549.38 CNY
Jan 1, 2020
12,694.26 CNY
Jan 1, 2021
24,372.25 CNY
Jan 1, 2022
49,958.06 CNY
Jan 1, 2023
85,187.15 CNY
Jan 1, 2024
91,234.88 CNY
Jan 1, 2025
97,398.05 CNY
The Shanghai Universal Biotech Co R&D per Employee history
YEARR&D per EmployeeYoY
97,398.05CNY+6.76%
91,234.88CNY+7.10%
85,187.15CNY+70.52%
49,958.06CNY+104.98%
24,372.25CNY+91.99%
12,694.26CNY+1.15%
12,549.38CNY+55.22%
8,085.03CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shanghai Universal Biotech Co Stock analysis

What does Shanghai Universal Biotech Co do? Shanghai Universal Biotech Co., Ltd. generates revenue through the provision of life science research services, including the supply of third-party brand life science instruments and consumables, alongside its own independent brand products. The company's life science reagents, such as immunological reagents based on antibodies and antibody-related reagents, molecular biology reagents, cell biology reagents, and biochemical reagents, are primarily sourced from third-party brands with supplementary independent brand offerings. Clients purchasing these products include research institutions and laboratories requiring comprehensive technical services like experimental services and technical support. The company focuses on life science instruments and consumables, covering detection, analysis, and sample preparation, while its comprehensive technical services support the operational needs of its clients. The business model emphasizes third-party brand products as the main supply, with independent brand products serving as a supplement. This approach allows Shanghai Universal Biotech to offer a diverse range of life science reagents and instruments without the need for extensive in-house manufacturing. The company's client base primarily consists of entities within the life science research sector seeking reliable reagents, instruments, and technical support to advance their scientific work. By leveraging third-party brands for core products and developing its own independent brand for supplementary offerings, the company optimizes its product portfolio to meet market demands effectively. Shanghai Universal Biotech's revenue streams are derived from the sale of life science reagents, instruments, and consumables, alongside comprehensive technical services. The life science reagents category includes immunological reagents, molecular biology reagents, cell biology reagents, and biochemical reagents, all of which are supplied through a mix of third-party and independent brands. Instruments and consumables focus on detection, analysis, and sample preparation, catering to the technical needs of research institutions. The comprehensive technical services, such as experimental services and technical support, further enhance the value proposition for clients requiring end-to-end solutions in life science research. Shanghai Universal Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Universal Biotech Co stock

R&D Spending per Employee of Shanghai Universal Biotech Co is 97,398.05 CNY in 2025.

R&D Spending per Employee of Shanghai Universal Biotech Co changed from 91,234.88 CNY to 97,398.05 CNY, representing a 6.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Shanghai Universal Biotech Co since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Shanghai Universal Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Shanghai Universal Biotech Co

All Key Metrics — Shanghai Universal Biotech Co